Navigation Links
Amedica® Receives Patent for Knee Prosthesis With Monoblock Silicon Nitride Ceramic Tibial Component
Date:8/31/2010

SALT LAKE CITY, Aug. 31 /PRNewswire/ -- Amedica Corporation, a spinal and orthopaedic implant and instrument company focused on unique silicon nitride (SiN) ceramic technologies, announced today that it has been granted United States Patent No. 7,776,085 B2, covering an improved knee implant prosthesis that features a monoblock ceramic tibial component for articulation with natural or prosthetic (resurfaced) femoral surfaces.  This is an important addition to Amedica's substantial and growing patent portfolio concerning silicon nitride hip and knee implants.

The tibial component is created from a silicon nitride monoblock adapted for fixation relative to a patient's tibial bone. Alternately, it can be affixed by a ceramic bearing insert component carried by a tibial baseplate member that is adapted for fixation relative to the tibial bone. In either form, the monoblock silicon nitride tibial component includes one or more upwardly concave articulation surface that promotes movable bearing engagement with a generally convex or condylar-shaped femoral articulation surface.

According to Ben Shappley, Chief Executive Officer, President and Director of Amedica, the monoblock silicon nitride technology with an innovative bone-contacting Bioactive™ surface provides implants with remarkable wear characteristics and extended service life. In the long term, the technology helps surgeons achieve more successful outcomes in restoring patient function and allows individuals to return to productive and pain-free lives.

"Improvements in knee prostheses using monoblock silicon nitride with bio-ingrowth technology in the tibial component eliminate conventional polymer-based bearing inserts and the related, undesirable wear debris problems and revisions associated with the older technologies used in current implants," said Shappley. "Our unique technology allows us to combine our high-strength silicon nitride with an ultra-low wear, surface-bearing technology that is designed for secure, lifetime fixation.  This gives surgeons flexibility in design choices and the ability to improve anatomic fit and function for positive, lasting results and significant outcome improvement."

Amedica, a full-line manufacturer and supplier of silicon nitride technologies that are used in spinal implant applications, has developed unique SiN materials having disruptive characteristics for spinal, hip and knee implant applications. The material is remarkably fracture resistant, and its articulating surfaces do not produce the wear debris that is linked to osteolysis-related re-operations. Additionally, the Bioactive implants provide a hydrophilic surface and a conductive cancellous structure that enhances bone ingrowth and attachment.

The company recently entered into a Joint Venture Agreement with Orthopaedic Synergies Inc., a global reconstructive hip and knee concern known for its innovative and new implant technologies, expanding its reach into a more widespread orthopaedic marketplace.

"This latest patent for expanded use of our monoblock silicon nitride technology further marks a notable milestone in orthopaedic implants and other related applications," Shappley notes. "It also further secures Amedica's future competitive position in the reconstructive implant segment, which is one of the largest and rapidly-growing segments in the industry."

About Amedica:

Amedica Corporation is ISO 13485 certified and its products are FDA cleared and CE approved.  Amedica Corporation is an emerging orthopaedic implant company focused on using its silicon nitride ceramic technologies to develop and commercialize a broad range of innovative, unique spine and total joint implants for the growing orthopaedic device market.  It has brought to market various spinal implant products, while products under development include reconstructive hip and knee implants that represent a new standard of care in total joint implants based on superior performance, safety and efficacy.


'/>"/>
SOURCE Amedica Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Amedica® Receives Patent for Hip Implant Using Monoblock Ceramic Technology
2. Bionovo Receives Positive Guidance from FDA on Menerba®
3. BioMarin Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe Disease
4. Bend Research Receives Patent for Preparing Spray-Dried Drug Dispersions Using Pressure Nozzles
5. Novartis receives FDA approval of Tekamlo™, a single-pill combination of aliskiren and amlodipine to treat high blood pressure
6. Endologix Receives CE Mark Approval for Expanded Line of Powerlink Products and PowerFit Aortic Extensions
7. KemPharm, Inc. Receives Notice of Issuance from USPTO on Second Patent Protecting Companys ADHD Prodrug Technology
8. Pentasa(R) - Shire Receives Ruling From FDA on Citizens Petition
9. +PLUSPAK (polymer bottle) Packaging Receives GEs Distinguished ecomagination(SM) Approval
10. PROLOR Biotech Receives FDA Clearance for a Phase II Trial of Its Long-Acting Human Growth Hormone in the U.S.
11. Celsion Receives Fast Track Designation for ThermoDox® Development Program to Treat Primary Liver Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2017)... -- Just 18 months after its February 2016 launch, market ... appointment of three new senior people to its rapidly ... and James Wright bring decades of ... Tammy Wynne joins as Director, Value ... has over ten years, experience in global market access ...
(Date:9/1/2017)... , Sept. 1, 2017  Bayer will present the ... European Society for Medical Oncology (ESMO) 2017 Congress, September 8-12 ... will include new preclinical and clinical data on Bayer,s marketed ... earlier pipeline projects. ... best minds in cancer research at ESMO," said Carsten ...
(Date:8/28/2017)... , Aug. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... on Monday, September 11, 2017, in New York ... executive officer, is scheduled to present at 11:05 a.m. Eastern ... accessed at http://ir.hill-rom.com/events.cfm . A recorded replay will be ... through December 10, 2017. ...
Breaking Medicine Technology:
(Date:9/22/2017)... ... ... “Fruit of the Spirit: “Love””: a delightful adventure of two friends who play ... Spirit: “Love”” is the creation of published author, Halimah Jones, who was born and ... an avid writer, her inspiration for “Fruit of the Spirit: “Love”” blossomed from her ...
(Date:9/22/2017)... Greenwich, Connecticut (PRWEB) , ... September 22, 2017 ... ... to conquering Lyme and other tick-borne diseases through research, education and awareness, today ... , A noted immunologist and microbiologist, Dr. Sellati has more than 20 ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... SABRE is ... run from September 11 to the end of November. , The Chicago, Illinois, based ... their community and teach them about the ease of taking their personal safety into ...
(Date:9/21/2017)... ... September 21, 2017 , ... Demonstrating a consistent ... health departments have been awarded five-year accreditation status through the Public Health ... being served by a PHAB-accredited health department now extend to more than ...
(Date:9/21/2017)... ... September 21, 2017 , ... The New England Center for Children® (NECC®), ... election of Yie-Hsin Hung to the Board of Directors. , “The New England ... Ms. Hung is an invaluable addition to our team,” said Vincent Strully, Jr., President ...
Breaking Medicine News(10 mins):